ImmuCell Corp
NASDAQ:ICCC

Watchlist Manager
ImmuCell Corp Logo
ImmuCell Corp
NASDAQ:ICCC
Watchlist
Price: 5.92 USD -3.74% Market Closed
Market Cap: 53.6m USD

Net Margin
ImmuCell Corp

8.4%
Current
-16%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.4%
=
Net Income
2.3m
/
Revenue
27.8m

Net Margin Across Competitors

No Stocks Found

ImmuCell Corp
Glance View

Market Cap
53.6m USD
Industry
Biotechnology

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company is headquartered in Portland, Maine and currently employs 60 full-time employees. The firm is engaged in development, acquisition, manufacture and sale of products that improve the health and productivity of dairy and beef cattle. The company manufactures and markets the First Defense product line for the prevention of scours in newborn dairy and beef calves. The company expanded this line into five different products with formulations targeting E. coli and coronavirus pathogens, as well as E. coli, coronavirus and rotavirus pathogens. Its Tri-Shield First Defense product line extension is calf-level, passive antibody product providing immediate immunity against E. coli, coronavirus and rotavirus. These product line provides Immediate Immunity to newborn calves. The firm is engaged in development of Re-Tain, a Nisin treatment for subclinical mastitis in lactating dairy cows. Its products reduce the use of traditional antibiotics in food producing animals.

ICCC Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.4%
=
Net Income
2.3m
/
Revenue
27.8m
What is the Net Margin of ImmuCell Corp?

Based on ImmuCell Corp's most recent financial statements, the company has Net Margin of 8.4%.

Back to Top